Showing results (331-340 of 373) with videos related to

Sort By:
Pageof 38
Histopathology|January 30, 2024
PD-L1 expression in resected lung adenocarcinoma: prevalence and prognostic significance in relation to the IASLC grading systemSoohyun Hwang, Tae Hee Hong, Hong Kwan Kim, et al.
Plos Genetics|June 7, 2008
Genomic profiling identifies GATA6 as a candidate oncogene amplified in pancreatobiliary cancerKevin A Kwei, Murali D Bashyam, Jessica Kao, et al.
Plos One|February 26, 2013
Low SP1 expression differentially affects intestinal-type compared with diffuse-type gastric adenocarcinomaHun Seok Lee, Cheol-Keun Park, Ensel Oh, et al.
The Journal of Molecular Diagnostics : JMD|December 19, 2012
Multiplexed gene expression and fusion transcript analysis to detect ALK fusions in lung cancerMaruja E Lira, Tae Min Kim, Donghui Huang, et al.
Cancer Research and Treatment|January 6, 2017
Patient-Derived Xenograft Models of Epithelial Ovarian Cancer for Preclinical StudiesEun Jin Heo, Young Jae Cho, William Chi Cho, et al.
Oncotarget|April 21, 2016
PIK3CA amplification is associated with poor prognosis among patients with curatively resected esophageal squamous cell carcinomaHyo Song Kim, Seung Eun Lee, Yoon Sung Bae, et al.
The Journal of Pathology|July 26, 2017
Molecular breakdown: a comprehensive view of anaplastic lymphoma kinase (ALK)-rearranged non-small cell lung cancerKa-Won Noh, Mi-Sook Lee, Seung Eun Lee, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|April 13, 2023
Whole-Section Landscape Analysis of Molecular Subtypes in Curatively Resected Small Cell Lung Cancer: Clinicopathologic Features and Prognostic SignificanceSoohyun Hwang, Tae Hee Hong, Hong Kwan Kim, et al.
Journal of Translational Medicine|August 9, 2020
PDX models of human lung squamous cell carcinoma: consideration of factors in preclinical and co-clinical applicationsHae-Yun Jung, Tae Ho Kim, Jong-Eun Lee, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|June 12, 2023
Longitudinal Monitoring of Circulating Tumor DNA From Plasma in Patients With Curative Resected Stages I to IIIA EGFR-Mutant Non-Small Cell Lung CancerHyun-Ae Jung, Bo Mi Ku, Yeon Jeong Kim, et al.
Pageof 38